The Centers for Medicare & Medicaid Services (CMS) posted a solicitation September 8 for comments proposing to extend collection of PACE Quality Data Monitoring and Reporting. CMS is also proposing a new data set: Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease to be used by the Office of Minority Health. This set will inform nominations for the CMS Health Equity Awards. Interested parties are invited to comment by the November 7 deadline. A link to the posting can be viewed in the Federal Register.